Related Experiment Video
Updated: May 27, 2026
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
Published on: June 13, 2019
Organoids in Cancer Research: Current Applications, Limitations, and Technological Advances
Sujeong Kim1, Se Eun Park1,2, Chanwoo Kim1,2
1DK lab, Chungbuk National University and Chungbuk National University Hospital, Cheongju, Korea.
Abstract:
Organoids are 3-dimensional cell culture systems derived from stem cells through self-organization. They recapitulate key aspects of tissue architecture and organ-specific functions, providing a powerful preclinical platform for cancer research. In particular, patient-derived tumor organoids preserve the pathological and genetic features of primary tumors. These models support the prediction of patient-specific drug responses and thereby advance precision medicine. Despite these advantages, several challenges remain, including incomplete reconstruction of the tumor microenvironment-particularly immune components- and insufficient vascularization. Recent advances have sought to address these limitations through innovative approaches, including immune cell co-culture systems and organoid-on-a-chip technologies. This mini-review summarizes recent progress in tumor organoid research and highlights emerging strategies aimed at improving physiological relevance. It also discusses future perspectives, emphasizing the expanding roles of organoids in precision oncology and regenerative medicine.
Insights
Patient-derived tumor organoids offer a powerful preclinical cancer research platform, advancing precision medicine by predicting drug responses. Ongoing research aims to improve their physiological relevance by incorporating tumor microenvironment components.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Stem Cell Biology
Background:
- Organoids are 3D cell cultures from stem cells, mimicking tissue structure and function.
- Patient-derived tumor organoids retain primary tumor characteristics, aiding precision medicine.
- Current limitations include incomplete tumor microenvironment reconstruction and poor vascularization.
Purpose of the Study:
- To review recent advancements in tumor organoid research.
- To highlight strategies for enhancing the physiological relevance of tumor organoids.
- To discuss future applications in precision oncology and regenerative medicine.
Main Methods:
- Review of recent literature on tumor organoid development and applications.
- Analysis of innovative approaches like immune cell co-culture and organoid-on-a-chip systems.
- Discussion of challenges and future directions in the field.
Main Results:
- Tumor organoids serve as effective preclinical models for cancer research.
- Patient-derived organoids enable prediction of patient-specific drug responses.
- Emerging technologies are addressing limitations in recreating the tumor microenvironment and vascularization.
Conclusions:
- Tumor organoids are crucial for advancing precision oncology and personalized medicine.
- Continued development is needed to fully replicate the complex tumor microenvironment.
- Organoid technology holds promise for regenerative medicine applications.
